InsidersTradesSigma
Follow the 티앤알바이오팹 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 티앤알바이오팹 has published 10 public disclosures. Market capitalisation: €126.5bn. The latest transaction was disclosed on 14 July 2026 (Sale). Among the most active insiders: 윤원수. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10 of 10 declarations
티앤알바이오팹 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing bio-printing technologies and solutions for regenerative medicine.